MA 13.01 Clinical and Pathological Variables Influencing Noninvasive Detection of Early Stage Lung Cancer Using Circulating Tumor DNA

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2017.09.560
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

MA23.02 Circulating Tumor DNA Analysis With a Novel Variant Classifier for Recurrence Detection in Resected, Early-Stage Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

Cancer Discovery
Oncology
2017English

Circulating Tumor DNA Detectable in Early- And Late-Stage Colorectal Cancer Patients

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

Circulating Tumor DNA Detection in Lung Cancer Patients Before and After Surgery

Scientific Reports
Multidisciplinary
2016English

Detection of Circulating Tumor DNA From Pancreatic Cancer Using Next-Generation Sequencing and Possible Clinical Applications

Suizo
2018English

Utility of Circulating Tumor DNA in Cancer Diagnostics With Emphasis on Early Detection

BMC Medicine
Medicine
2018English

Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2020English

P1.09-21 Circulating Tumor DNA Improves Genotypification and Detection of Targetable Alterations in Selected Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Detection of Cancer Specific Mutations in Early-Stage Non-Small Cell Lung Cancer Using Cell-Free DNA by Targeted Sequencing

International Journal of Oncology
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy